Skip to main content

GOLDMAN SACHS GROUP INC

Position in OCUL — Ocular Therapeutix, Inc

CIK 886982 NEW YORK, NY

Position in OCUL

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$17,300,423
+$7,895,624 QoQ
Shares Held
1,761,754
+58.7% QoQ
Ownership
0.802%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#18
of 257 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in OCUL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $13,039,430,805 across 359 Biotechnology names. OCUL ranks #122 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in OCUL

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $17,300,423 1,761,754
2026-03-31 $9,404,799 1,110,366
2025-12-31 $18,786,928 1,547,523
2025-09-30 $9,304,865 795,968
2025-06-30 $5,615,930 605,165
2025-03-31 $4,266,125 582,009
2024-12-31 $5,744,191 672,622
2024-09-30 $5,013,269 576,238
2024-06-30 $4,647,211 679,417
2024-03-31 $2,449,546 269,181
2023-12-31 $390,485 87,553
2023-09-30 $362,311 115,386
2023-06-30 $1,070,658 207,492
2023-03-31 $952,103 180,665
2022-12-31 $512,079 182,235
2022-09-30 $1,380,899 332,747
2022-06-30 $1,882,356 468,248
2022-03-31 $1,902,729 384,390
2021-12-31 $1,511,297 216,829
2021-09-30 $3,187,660 318,766
2021-06-30 $6,901,348 486,696
2021-03-31 $10,465,460 637,749
2020-12-31 $10,464,408 505,527
2020-09-30 $950,876 124,951
2020-06-30 $1,754,447 210,618
2020-03-31 $421,423 85,136